返回
Integrative workflows for network analysis
DOI:10.1042/EBC20180005.png)
摘要
En 中文
Due to genetic heterogeneity across patients, the identification of effective disease signatures and therapeutic targets is challenging. Addressing this challenge, we have previously developed a network-based approach, which integrates heterogeneous sources of biological information to identify disease specific core-regulatory networks. In particular, our workflow uses a multi-objective optimization function to calculate a ranking score for network components (e.g. feedback/feedforward loops) based on network properties, biomedical and high-throughput expression data. High ranked network components are merged to identify the core-regulatory network(s) that is then subjected to dynamical analysis using stimulus-response and in silico perturbation experiments for the identification of disease gene signatures and therapeutic targets. In a case study, we implemented our workflow to identify bladder and breast cancer specific core-regulatory networks underlying epithelial-mesenchymal transition from the E2F1 molecular interaction map. In this study, we review our workflow and described how it has developed over time to understand the mechanisms underlying disease progression and prediction of signatures for clinical decision making.
Keyword:
GENE
RECONSTRUCTION
PATHWAYS
DATABASE
MOTIFS
期刊
S
IF:
0
论文数:
13
被引数:
5
机构
引用论文
HTRIdb: an open-access database for experimentally verified human transcriptional regulation interactions
BMC GENOMICS
IF3.7
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series在TRANSBIG多中心独立验证系列中,淋巴结阴性乳腺癌患者76基因预后签名的强时间依赖性
CLINICAL CANCER RESEARCH
IF10.2
News media narratives of Covid-19 across 20 countries: Early global convergence and later regional divergence
PLOS ONE
IF0
Unraveling a tumor type-specific regulatory core underlying E2F1-mediated epithelial-mesenchymal transition to predict receptor protein signatures揭开E2F1-mediated上皮-间质转化的肿瘤类型特异性调节核心,以预测受体蛋白特征
NATURE COMMUNICATIONS
IF15.7

